Company page
Olix Pharmaceuticals, Inc.
Olix Pharmaceuticals, Inc. is a public company traded under the ticker 226950 on the Korean market. The company has a market capitalization of approximately 1.77 trillion KRW. Olix focuses on developing innovative therapies based on its proprietary RNAi technology.
- Ticker
- 226950:KRX
- Asset type
- Stock
- Market cap
- $1.77B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW